NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
High Performance Liquid Chromatography (HPLC)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Antiretroviral Level, Kaletra FORWARD
Specimen Type Describes the specimen type needed for testing
Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
Draw blood in a plain red-top tube(s). (Serum gel tube is not acceptable.) Spin down and send 2 mL of serum frozen in plastic vial.
Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Specimens other than
Anticoagulants other than
Cold reject; Warm reject
Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Results are expressed in mcg/mL
Kaletra levels peak approximately 4 hours after administration of
400 mg lopinavir/100 mg ritonavir. The mean peak concentration
is approximately 22% lower for the oral solution than the capsule
formulation under fasting conditions. To enhance bioavailability,
Kaletra oral suspension should be taken with food.
HIV-1 infected adults, 400/100 mg twice daily x 3 weeks.
Lopinavir mean steady state trough level:
7.1 + or - 2.9 mcg/mL
Lopinavir mean peak level:
9.8 + or - 3.7 mcg/mL
Pediatric lopinavir levels are similar to those obtained in adult patients.
Test Performed by: Focus Diagnostics, Inc.
5785 Corporate Ave.
Cypress, CA 90630-4750
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
5 - 6 days
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
7 - 8 days
Performing Laboratory Location The location of the laboratory that performs the test
Focus Diagnositics, Inc.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|